+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hemoglobin Testing Market Report by Product Type, Technology, End-User, and Region 2023-2028

  • PDF Icon


  • 138 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912054

Quick Summary:

In the rapidly evolving global healthcare landscape, hemoglobin testing represents a vital component for diagnosing and monitoring various medical conditions. As a senior business executive, understanding the intricacies of the hemoglobin testing market can be crucial to making informed decisions in the healthcare sector.

This market research report is designed to equip you with comprehensive insights into the hemoglobin testing market dynamics. The extensive adoption of these tests in the management of chronic conditions and their relevance in routine health assessments form the core drivers of market expansion. The demand for precise diagnostics is particularly amplified by the prevalence of diabetes and anemia, necessitating regular monitoring for effective disease management.

Furthermore, the market is propelled by robust advancements in healthcare infrastructure, growing health expenditure, and an escalating awareness of blood disorders. Technological innovations, along with favorable insurance reimbursements, serve as catalysts fostering market growth. This report offers granulated analysis across various segments including product type, technology, and end-users, equipping you with the strategic insights to navigate the complexities of the hemoglobin testing market.

The global hemoglobin testing market size reached US$ 2.3 Billion in 2022. Looking forward, the market is expected to reach US$ 3.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.20% during 2022-2028.

A hemoglobin test measures the count of red blood cells (RBC) or the level of hemoglobin in the blood. Hemoglobin is a type of protein present in the RBCs that carries oxygen to the organs and transports carbon dioxide back to the lungs. Hemoglobin tests are used extensively by doctors as a part of their routine check-ups or to diagnose a serious medical condition in the patient. If a test reveals that the hemoglobin level in an individual’s body is lower than normal, it means that they have a low RBC count and are prone to disorders such as anemia. If the RBC count is higher than normal, it could be an indication for a blood disorder or can be caused by living at a high altitude, smoking and dehydration. The key end users of hemoglobin testing market are medical laboratories, hospitals and research centers.

An increasing prevalence of chronic disorders such as anemia and diabetes represent a key factor driving the global hemoglobulin testing market. In 2018, an estimated 490 Million people around the world suffered from diabetes. The prevalence of diabetes is currently being catalysed by an increasing ageing population, poor dietary habits, sedentary lifestyles and rising levels of obesity. Patients suffering from diabetes need to undergo tests to measure blood glucose and HbA1c levels regularly, driving the demand for such tests. Moreover, factors such as favourable reimbursement of hemoglobin testing under various health insurance policies is also catalyzing the growth of the market. However, in many countries, medical insurance doesn’t fully reimburse the cost of hemoglobin testing, but with partial payment and other coverages, consumers are increasingly adopting regular and periodic tests in order to check and maintain their overall health. Furthermore, factors such as improving health infrastructure, increasing per capita expenditure on health care, rising awareness for blood-related ailments, ageing population, technological advancements, etc. are also projected to drive the global hemoglobin testing market in the coming years.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global hemoglobin testing market report, along with forecasts at the global and regional level from 2023-2028. The report has categorized the market based on product type, technology and end-user.

Breakup by Product Type:

  • Reagents and Consumables
  • Equipment

Breakup by Technology:

  • Chromatography
  • Immunoassay

Breakup by End-User:

  • Laboratories
  • Hospitals
  • Research Centers

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Alere, ACON Laboratories, ARKRAY, Bayer Medical Care, Daiichi Biotech, DiaSys Diagnostic Systems, Epinex Diagnostics, Erba Diagnostics, etc.

Key Questions Answered in This Report:

  • How has the global hemoglobin testing market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global hemoglobin testing industry?
  • What has been the impact of COVID-19 on the global hemoglobin testing industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global hemoglobin testing industry?
  • What are the key driving factors and challenges in the global hemoglobin testing industry?
  • What is the structure of the global hemoglobin testing industry and who are the key players?
  • What is the degree of competition in the global hemoglobin testing industry?
  • What are the profit margins in the global hemoglobin testing industry?
Frequently Asked Questions about the Global Hemoglobin Testing Market

What is the estimated value of the Global Hemoglobin Testing Market?

The Global Hemoglobin Testing Market was estimated to be valued at $2.3 Billion in 2022.

What is the growth rate of the Global Hemoglobin Testing Market?

The growth rate of the Global Hemoglobin Testing Market is 6.2%, with an estimated value of $3.3 Billion by 2028.

What is the forecasted size of the Global Hemoglobin Testing Market?

The Global Hemoglobin Testing Market is estimated to be worth $3.3 Billion by 2028.

Who are the key companies in the Global Hemoglobin Testing Market?

Key companies in the Global Hemoglobin Testing Market include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc. and Taisho Pharmaceutical Holdings Co. Ltd.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hemoglobin Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Technology
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Product Type
6.1 Reagents and Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Equipment
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Chromatography
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunoassay
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End-User
8.1 Laboratories
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Research Centers
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 Europe
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 North America
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.2 Bio-Rad Laboratories
14.3.3 Danaher
14.3.4 EKF Diagnostics
14.3.5 F. Hoffmann-La Roche
14.3.6 Siemens Healthineers
14.3.7 Thermo Fisher Scientific
14.3.8 Alere
14.3.9 ACON Laboratories
14.3.10 ARKRAY
14.3.11 Bayer Medical Care
14.3.12 Daiichi Biotech
14.3.13 DiaSys Diagnostic Systems
14.3.14 Epinex Diagnostics
14.3.15 Erba Diagnostics

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Alere
  • ACON Laboratories
  • Bayer Medical Care
  • Daiichi Biotech
  • DiaSys Diagnostic Systems
  • Epinex Diagnostics
  • Erba Diagnostics